RETRACTED: Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1.

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Panels from Figures 1B and 3C appear similar to panels from Figure 7E of the article previously published by Yantao Han, Xiuwei Yang, Ning Zhao, Jianjun Peng, Hui Gao and Xia Qiu in the American Journal of Cancer Research 6(12) (2016) 2755-2771 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199752/, Figure 1C of the article published by C.-L. Xue, H.-G. Liu, B.-Y. Li, S.-H. He and Q.-F. Yue in the European Review for Medical and Pharmacological Sciences 23 (2019) 5101-5112 https://www.europeanreview.org/wp/wp-content/uploads/5101-5112.pdf and Figure 1C of the article published by Zhao Ma, Xuebin Bao and Junbao Gu in Life Sciences 218 (2019) 47-57 https://doi.org/10.1016/j.lfs.2018.12.027. Also, panels from Figure 5B appear similar to panels from Figure 8C of the article published by Kaili Liu, Hui Gao, Qiaoyun Wang, Longyuan Wang, Bin Zhang Zhiwu Han, Xuehong Chen, Mei Han and Mingquan Gao in Cancer Science 109 (2018) 1369-1381 https://doi.org/10.1111/cas.13575 and Figure 8D of the article published by Xiangyang Dou, Meihua Wang, Tao Zhang and Jiapei Yao in the Anatomical Record 303 (2020) 3117-3128 https://doi.org/10.1002/ar.24324. Although this article was published earlier than most of the other articles, the Editor decided to retract this article given concerns about the reliability of the data. The first author reported to the journal that the article was submitted without the awareness of the last author and by using an illegitimate email address that included the name of the last author.